Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.10
-0.75 (-2.79%)
Sep 17, 2025, 11:58 AM CST
-2.79%
Market Cap1.95B
Revenue (ttm)563.09M
Net Income (ttm)-178.49M
Shares Out72.45M
EPS (ttm)-2.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume185,340
Average Volume826,971
Open26.85
Previous Close26.85
Day's Range25.75 - 27.05
52-Week Range14.30 - 29.60
Beta0.19
RSI65.95
Earnings DateNov 13, 2025

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements

News

There is no news available yet.